OPEN Summit graphic for website

Guest speakers

Day 1: Tuesday, October 7, 3:00 – 3:15 pm

Jeff PostonJeff Poston, B.Pharm, PhD
Past Executive Director, Canadian Pharmacists Association
Past Director, Research and Professional Development at Canadian Pharmacists Association
Past Lecturer, Assistant Director, Medicines Research Unit at Welsh School of Pharmacy, University of Wales, Cardiff

Jeff Poston has been recognized as a pioneer in pharmacy practice research. He came to Canada as CPhA’s first Director of Research and Practice Development and has recently retired from his role as the Association’s Executive Director.

Jeff has a PhD in pharmacoepidemiology from the University of Wales.

Jeff’s presentation will consider how OPEN fits into the current healthcare context, explore trends in pharmacy practice research and highlight some considerations for future research.

• • • • • • • • • • • •

Day 2: Wednesday, October 8, 9:00 – 9:30 am

Nancy WinsladeNancy Winslade, BSc.Phm., PharmD, M.H.P.E.
Adjunct Professor, Faculty of Medicine, McGill University
President, Winslade Consultants Inc.
Member, Pharmacist services evaluation framework project, OPEN

As an Associate Professor at the University of Toronto in the early 1990s, Nancy practiced pharmacy at Sunnybrook Medical Centre and developed the Faculty of Pharmacy’s post-baccalaureate PharmD program. While residing in Europe from 1994–2003, she completed her master’s degree in health professions education at the University of Maastricht and consulted in health policy, curriculum development and performance assessment of healthcare professionals. Upon her return to Canada, Nancy joined the Medical Office of the 21st Century research project at McGill University’s Faculty of Medicine. At McGill, Nancy provides support to the clinical informatics research team in the areas of medication reconciliation, drug policy, therapeutics, methodology and national networking.

Nancy’s research focuses on using administrative databases to both evaluate the quality of care provided by practising pharmacists and to determine system-based factors that influence this quality of care. Nancy also continues her consulting work with primarily national organizations, including the Canadian Forces, the Canadian Patient Safety Institute, the Association of Faculties of Pharmacy of Canada, and the Canadian Association of Physician’s Assistants. Her present work is with the Canadian National Drug Safety and Effectiveness Network and the American National Organization of Nurse Practitioner Faculties.

Nancy’s presentation will address two areas of her research —

  • Using community pharmacists’ billing data to evaluate the appropriateness and impact of new services
    Results from several research projects using the RAMQ billing data from more than 1,800 community pharmacists in Quebec will be reviewed, including methodologies to measure both the types of medication management problems patients present with to community pharmacists and the development of indicators to measure the quality of community pharmacists care.
  • Electronic medication reconciliation to decrease readmissions post discharge
    The ongoing McGill-MUHC Medication Reconciliation trial will be described and the RightRx electronic medication reconciliation software demonstrated.

• • • • • • • • • • • •

Panellists

Maureen CharleboisMaureen Charlebois, CHE, MHSc, BScN, RN
Chief Nursing Executive & Group Director, Clinical Adoption, Canada Health Infoway
Member, Advisory Committee, Ontario Pharmacy Research Collaboration

Maureen is a patient-focused leader who is passionate about improving healthcare services across the continuum of care. In addition to her current position as Chief Nursing Executive and Group Director at Canada Health Infoway, Maureen  has previously held senior leadership positions, including Vice President & Chief Nursing Executive at Rouge Valley Health System; Director Emergency, Ambulatory and Critical Care at Markham Stouffville Hospital; Director Client Services at York Region Community Care Access Centre; Corporate Director and Strategic Business Lead at Leisureworld, Long Term Care facilities and Senior Business Lead for the Ontario Ministry of Health and Long-Term Care, Continuing Care eHealth division.

Maureen has also served as a surveyor with Accreditation Canada, and is a past board member on Canada’s Health Informatics Association, the Canadian Virtual Health Library and the Canadian College of Health Service Executives Toronto GTA Chapter.

• • • • • • • • • • • •

Dennis DarbyDennis Darby, P.Eng., ICD.D.
Chief Executive Officer, Ontario Pharmacists Association
Member, Advisory Committee, Ontario Pharmacy Research Collaboration

Since being appointed CEO of the Ontario Pharmacists Association in March 2008, Dennis has led the Association representing the professional view of more than 14,000 pharmacists and pharmacists-in-training in Ontario. His mandate includes promoting the role of pharmacists as healthcare providers with expanded scope of practice, building member services at OPA (including education), and leading the board’s strategic plan. Dennis brings over 20 years of government relations, public relations, business development and administrative experience to this role.

Dennis joined OPA from Procter & Gamble where, as Director of North America External Relations, he led a team of senior professionals charged with building and protecting the image and reputation of Procter & Gamble and its brands. He has extensive experience working with a wide variety of stakeholders including governments and regulatory agencies, professional and trade associations, consumer advocacy organizations, and business media. Before that, Dennis led research and development groups for Procter & Gamble in Europe and North America.

He has served as Chair of Stewardship Ontario, the provincial body that oversees the Blue Box Program, the Canadian Consumer Specialty Products Association and the Canadian Cosmetics Toiletries and Fragrances Association. He was a board member of the St. John’s Rehab Hospital and the St. John’s Rehab Foundation. Currently, Dennis serves on the boards of Opera Ontario, and the Canadian Toiletry & Fragrances Association Charitable Foundation. He is Co-Chair of the Ontario Government’s Pharmacy Council and Past Chair of the Ontario Health Providers Alliance.

Dennis graduated from McMaster University in 1984 with a degree in Chemical Engineering and Management, and he is a registered Professional Engineer in Ontario. He achieved the ICD.D. designation from the Rotman School of Management, University of Toronto in 2011.

• • • • • • • • • • • •

Donnie EdwardsDonnie Edwards, RPh, BScPhm
Co-owner, Boggio & Edwards IDA Pharmacy
Member, Advisory Committee, Ontario Pharmacy Research Collaboration

As a community pharmacist, Donnie’s focus is on pain management, women’s health, and addiction services. He has been appointed to the Narcotics Monitoring Working Group by the Ministry of Health and Long-Term Care, to advise on managing and evaluating data created by the Narcotics Monitoring System.

Previously, Donnie served as Ontario Pharmacists Association’s Chair of the Board, and went on to become the interim CEO of the association, where he increased OPA’s presence among government and stakeholders, and promoted the role of the pharmacist as a provider of frontline healthcare. As Chair of the Board, he advanced the mandate and efforts of the Board and expanded OPA’s scope; his participation in discussions regarding the Transparent Drug System for Patients Act contributed to the development of the MedsCheck program.

Donnie has also acted as Chair of OPA’s External Relations Committee, served on various committees, was an active voice for the Ontario Community Pharmacies Coalition, initiated OPA’s Drugs of Addiction strategy, was involved in the United Way, AIDS Niagara, and other local associations, played a key role in implementing school-based drug education programs across Canada.

Donnie is a sought-after speaker who increased the profile of pharmacists and has conducted hundreds of media interviews.

• • • • • • • • • • • •

Perry EisenschmidPerry Eisenschmid, BBA, MBA, C.Dir., H.R.C.C.C.
Chief Executive Officer, Canadian Pharmacists Association
Member, Advisory Committee, Ontario Pharmacy Research Collaboration

Perry is a member of the Centre for Chief Marketing Executives and the Canadian Society of Association Executives, and has extensive experience in marketing financial services, consumer packaged goods and not-for-profit member services. His broad expertise includes marketing, sales and information technology with specific interest in strategy, branding, product management, web and social media innovation.

Before joining CPhA, Perry was the Vice President of Marketing, Sales and IT with the Conference Board of Canada. He also had business responsibility for the organization’s multimillion dollar subscription and publications business and its web-based distribution channel. He was President and CEO of CIBC Trust and an executive for several years in CIBC’s Wealth Management Group.

• • • • • • • • • • • •

Shannon Fenton, PhD
Manager, Research Unit, Planning, Research and Analysis Branch, Ministry of Health and Long-Term Care

Shannon works in an area of the Ministry of Health and Long-Term Care that acts as a focal point for policy-relevant research evidence. She manages the Research Unit, which provides funding to high-impact programs of research and knowledge translation and exchange (KTE). Through its funding and KTE activities, the Research Unit helps to build the evidence base for health sector decision-making, ultimately supporting improvements to service efficiency and patient outcomes across the province. Shannon has previously played similar roles, bridging research and decision-making, in the Ministry of Children and Youth Services, and the Ministry of Education.

• • • • • • • • • • • •

Brent FraserBrent Fraser, BSc Phm, MBA
Director, Drug Programs Services Branch, Ministry of Health and Long-Term Care
Member, Advisory Committee, Ontario Pharmacy Research Collaboration

In addition to being a practicing pharmacist, Brent Fraser is also the Director of Drug Program Services with the Ontario Public Drug Programs at the Ministry of Health and Long-Term Care.

Brent has been involved in a number of reviews of Ontario’s drug system and leading the implementation of the review recommendations. He is a representative on national working groups for public drug policy.

• • • • • • • • • • • •

Dawn JenningsDawn Jennings, BSc Pharm, R.Ph.
Clinical Director, Pharmacy Services, HealthPRO Canada
Member, Advisory Committee, Ontario Pharmacy Research Collaboration

Dawn manages the Drug Shortages Portfolio at HealthPRO Canada. Her career in hospital pharmacy includes a concentration in oncology, and a position as Manager of Pharmacy at Sault Area Hospital. At the Sault Area Hospital, Dawn planned and executed the New Hospital Move for the department of Pharmacy and Cancer Clinic Pharmacy. She also championed the medication management system, two successful accreditation cycles, and spearheaded multiple medication safety initiatives.

Dawn has also been involved with various teaching and mentorship roles, including Teaching Associate for University of Toronto School of Pharmacy, Ferris State University School of Pharmacy, University of Waterloo School of Pharmacy, Ontario College of Pharmacists, and Part Time Professor for Sault College Pharmacy Technician Program within Health Sciences.

She has held various advisory positions, including board appointment to the Sault College Pharmacy Technician Advisory Committee, Chair of Pharmacy Advisory Committee for HealthPRO representing over 300 hospitals across Canada, Chair of Product Evaluation Committee, active member of Drug Shortage Task Force , Northern Ontario Chapter Chair Delegate and President for Canadian Society of Hospital Pharmacists Ontario Branch(CSHP-Ontario Branch), Professional Practice Committee Member of Ontario Pharmacists Association (OPA-PPC), Examination Committee Member for the Pharmacy Examining Board of Canada (PEBC), and Board member of Joint Group Health and SAH Review and Ethics Committee.

• • • • • • • • • • • •

Wade ThompsonWade Thompson, HBSc, BScPhm, RPh
MSc candidate, clinical epidemiology
Department of Epidemiology and Community Medicine, University of Ottawa
Research project coordinator, Deprescribing guidelines for the elderly project

Wade is a research project coordinator at the Bruyère Research Institute, involved in projects investigating interprofessional competencies for managing polypharmacy in older persons as well as deprescribing. His role on OPEN’s Deprescribing guidelines for the elderly project is to coordinate the development of the second and third deprescribing guidelines.

In addition to his position at Bruyère, Wade is also a clinical pharmacist at the Arnprior and District Family Health Team. Wade recently graduated from the pharmacy program at the University of Waterloo. Wade’s interest in medication management in older persons is leading him to pursue further research training in the area as well as continuing to work clinically.

• • • • • • • • • • • •

Sandra WinkelbauerSandra Winkelbauer, BScPhm
Manager of Continuing Competency, Ontario College of Pharmacists
Member, Advisory Committee, Ontario Pharmacy Research Collaboration

Sandra, a pharmacist with experience in adult education, is the Manager of Continuing Competency at the Ontario College of Pharmacists. Her role focuses on quality assurance, including continuing professional development, self-assessment, learning portfolio usage and peer / practice review.

Sandra is also currently the president of the Canadian Council on Continuing Education in Pharmacy. On a part-time basis, Sandra works as a drug information pharmacist for the Telehealth service, at the Drug Information and Research Centre. Before joining the College, Sandra was the Director of Education at the Ontario Pharmacists Association. She also has experience as a hospital pharmacist, having worked at the Hospital for Sick Children and at Sunnybrook Health Sciences Centre.